Acivir Pills are an antiviral medication primarily used to treat infections caused by the herpes simplex virus (HSV) and varicella-zoster virus (VZV). The active ingredient in Acivir is acyclovir, a synthetic nucleoside analogue that inhibits viral DNA replication. Available in oral tablet form, Acivir is prescribed for conditions such as genital herpes, cold sores (herpes labialis), chickenpox, and shingles (herpes zoster). This report provides a detailed overview of Acivir Pills, including their pharmacological action, indications, dosage guidelines, potential side effects, drug interactions, and important precautions.

Pharmacological Mechanism of Action

Acyclovir exerts its antiviral effect by interfering with the replication of herpes viruses. After oral administration, acyclovir is phosphorylated by viral thymidine kinase to acyclovir monophosphate, which is then converted to acyclovir triphosphate by cellular enzymes. This active triphosphate form competitively inhibits viral DNA polymerase and incorporates into viral DNA, resulting in chain termination and prevention of further viral replication. Acyclovir has a high affinity for viral thymidine kinase, making it selectively toxic to virus-infected cells. Its activity is most pronounced against herpes simplex virus types 1 and 2 and varicella-zoster virus.

Indications and Approved Uses

Acivir Pills are indicated for the treatment of:

• Genital Herpes (HSV-2): Used for initial episodes, recurrent episodes, and suppressive therapy to reduce the frequency and severity of outbreaks.
  
• Herpes Labialis (Cold Sores): For the treatment of recurrent cold sores on the lips and face.
  
• Herpes Zoster (Shingles): Acivir can reduce the duration of pain, rash healing time, and the risk of post-herpetic neuralgia when initiated within 72 hours of rash onset.
  
• Varicella (Chickenpox): Used in immunocompromised patients or in otherwise healthy individuals with severe or prolonged infection.
  
  

Acivir is also sometimes used off-label for other herpesvirus infections, but this report focuses on approved indications.

Dosage and Administration

Acivir Pills are available in standard strengths of 200 mg, 400 mg, and 800 mg. The dosage depends on the condition being treated, the patient's renal function, and age.

• Genital Herpes (Initial Episode): 200 mg every 4 hours (5 times daily) for 40mg [http://lafarolashop.com/producto/prednisolone/] 10 days.
  
• Genital Herpes (Recurrent Episode): 200 mg every 4 hours (5 times daily) for 5 days, or 400 mg 3 times daily for 5 days.
  
• Suppressive Therapy for Genital Herpes: 400 mg twice daily, or 200 mg 3 times daily, often continued for up to 12 months.
  
• Herpes Zoster (Shingles): 800 mg every 4 hours (5 times daily) for 7 to 10 days.
  
• Varicella (Chickenpox): For children over 2 years: 20 mg/kg (up to 800 mg) 4 times daily for 5 days. For adults: 800 mg 4 times daily for 5 days.
  
  

Doses must be adjusted in patients with impaired renal function, especially those with creatinine clearance below 10–25 mL/min. Acyclovir is primarily excreted unchanged by the kidneys, so dose reduction and extended intervals are necessary to avoid toxicity.

Pharmacokinetics

Oral acyclovir has variable bioavailability, averaging about 15–30% after a 200 mg dose. Absorption is not significantly affected by food. Peak plasma concentrations occur within 1.5–2 hours. The drug distributes widely into body tissues and fluids, including cerebrospinal fluid and genital lesions. Acyclovir crosses the placenta and is excreted in breast milk. The elimination half-life is about 2.5–3.5 hours in adults with normal renal function, but can increase to 20 hours in anuria.

Adverse Effects

Acivir Pills are generally well-tolerated, but side effects can occur:

• Common: Nausea, diarrhea, headache, and dizziness. These are usually mild and transient.
  
• Less Common: Vomiting, abdominal pain, skin rash, fatigue, and fever.
  
• Serious but Rare: Neurotoxicity (confusion, hallucinations, seizures, coma), especially in elderly patients or those with renal impairment. Acute renal failure can occur due to crystallization of acyclovir in the renal tubules, mostly with rapid intravenous administration but possible with high oral doses in dehydration.
  
• Hypersensitivity: Anaphylaxis, angioedema, and Stevens-Johnson syndrome are extremely rare.
  
  

Long-term use for suppressive therapy has not been associated with cumulative toxicity, but periodic monitoring of renal function is advisable.

Drug Interactions

• Probenecid: Reduces renal clearance of acyclovir, increasing its plasma concentration and risk of toxicity.
  
• Cimetidine and Other Drugs Affecting Renal Tubular Secretion: May increase acyclovir levels.
  
• Nephrotoxic Agents (e.g., aminoglycosides, cyclosporine, tacrolimus): Co-administration may increase the risk of renal impairment.
  
• Zidovudine: Acyclovir has been associated with increased neurotoxicity when used with zidovudine, though causal relationship is unclear.
  
  

Patients should inform their healthcare provider of all medications they are taking.

Contraindications and Precautions

Acivir Pills are contraindicated in patients with known hypersensitivity to acyclovir or valacyclovir (the prodrug). Caution is required in:

• Renal Impairment: Dose adjustment and adequate hydration are essential to prevent crystalluria.
  
• Elderly Patients: Higher risk of neurotoxicity and renal dysfunction.
  
• Pregnancy and Breastfeeding: Acyclovir is classified as Pregnancy Category B (animal studies show no risk, but human data are limited). It is generally considered safe for use during pregnancy when benefit outweighs risk, especially for severe herpes infections. Acyclovir is excreted in breast milk, but infant exposure is low.
  
• Dehydration: Patients should be encouraged to drink plenty of fluids during therapy.
  
  

Efficacy and Clinical Considerations

Acyclovir is a well-established antiviral with decades of clinical use. For genital herpes, it reduces the duration of viral shedding, lesion healing time, and pain if started early. Suppressive therapy can reduce recurrence rates by 70–80%. For shingles, acyclovir shortens the acute phase and may lower the incidence of post-herpetic neuralgia. In chickenpox, it reduces fever and number of lesions when begun within 24 hours of rash onset. However, resistance has emerged, particularly in immunocompromised patients, through mutations in thymidine kinase or DNA polymerase.

Comparison with Valacyclovir and Famciclovir

Valacyclovir, the L-valyl ester prodrug of acyclovir, offers improved oral bioavailability (about 55%), allowing less frequent dosing and higher plasma levels. Famciclovir (prodrug of penciclovir) has a similar spectrum but different pharmacokinetics. Acivir Pills (acyclovir) remain a cost-effective option, especially in resource-limited settings.

Conclusion

Acivir Pills (acyclovir) are a cornerstone in the management of herpesvirus infections. Their mechanism of action is selective and well-understood, with a favorable safety profile. Proper dosing, attention to renal function, and early initiation of therapy are key to achieving best outcomes. Patients should be counseled about the contagious nature of herpes infections and the importance of using barrier protection during sexual activity. While newer antivirals offer convenience, acyclovir continues to be widely prescribed due to its efficacy, safety, and affordability.